Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by wasagastaron Jun 19, 2017 3:45pm

167 Views

Post# 26379433

RE:More instructive than Bunge's pathetic whining ...

Thanks Bencro - just amazing technology developed by the Theralase team of researchers - incredible really. those who are complaining about the stock price, can you just for a moment appreciate the technology, the advancement made and anticipate greater things shortly? Those that constantly whine about the price seem to be here only for a quick buck. Well soon you will get your quick buck. But those that really comprehend and appreciate the technology will get more than a quick buck.

bencro wrote:

More instructive (and constructive) than Bunge's pathetic whining about share price and paper losses ...

Potent and selective photo-inactivation of proteins with peptoid-ruthenium conjugates : Nature Chemical Biology : Nature Research

"When the ruthenium absorbs visible light, it has to dump that energy to return to a normal state. In the process, it produces an extremely reactive form of oxygen that rips apart whatever proteins it happens to encounter. Basically, it destroys those proteins forever."

The new technique offers researchers rapid access to some very potent, very selective light activated compounds that can knock out specific protein function, an important strategy in research into diseases such as cancer. Since light can be focused with high spatial resolution, this technology may open the door for knocking out proteins in only one region of a single cell, but not another, allowing, for example, the inactivation of a target protein in the nucleus, but not in the cytoplasm that surrounds it.